Akorn Inc. News
Generic-Drug Maker Akorn Files Chapter 11
Generic-drug maker Akorn filed a Chapter 11 petition. A deal with its lenders will enable it to continue a search for a buyer.
Drugmaker Akorn Receives FDA Warning Letter Regarding N.J. Facility
Akorn receives a warning letter from the U.S. Food & Drug Administration regarding an inspection of the company's facility in Somerset, New Jersey.
Dow Loses Steam as Yields Hover Near 3% Threshold
The S&P 500 finished slightly higher, up just 0.01%.
Akorn's Stock Crashes as Germany's Fresenius Ends Takeover Amid Data Allegations
Akorn shares plummeted Monday after Germany's Fresenius Medical ditched its planned $5 billion takeover amid allegations of data misconduct at the Lake Forest, Ill.-based generic drugmaker.
Alphabet Earnings and 4 Other Business Stories You Must Know Monday Morning
Happy Monday! These are the headlines you need to see during your morning commute.
Alphabet Earnings, Bond Yields Rise, Akorn Plunges - 5 Things You Must Know
Stock futures are mostly lower as benchmark 10-year Treasury notes inch closer to 3%; Google parent Alphabet, T-Mobile US and Hasbro report earnings; Akorn plunges after Germany's Fresenius drops its planned $5 billion takeover of the generic drugmaker.
Global Stocks Slip as 3% 10-Year Yields, Bad Tech News Unsettle Markets
The U.S. earnings seasons accelerates this week with 180 S&P 500 companies reporting, including big tech names such as Google, Facebook, Amazon and Microsoft.
Akorn Shares Plunge After Fresenius Warns on Takeover Amid Data Breach Probe
Germany's Fresenius SE said a probe into alleged data breaches at Akorn could scupper its planned $5 billion takeover of the Lake Forest, Ill.-based generic drugmaker.
Stock Futures Improve After Fed's Powell Repeats 'Gradual' Rate Hike Aim
Global stocks were mixed in early Tuesday trading as investors sifted through prepared remarks ahead of the first of two appearances on Capitol Hill this week by new Fed chairman Jerome Powell.
Teva, Mylan Seen to Stay on M&A Sidelines
Teva is 'in no shape' to be making acquisitions while Mylan is 'still pretty leveraged,' says Oppenheimer analyst Derek Archila.
Breaking News
The Arena Group Q2 Gross Profit Nearly Doubles; Revenue Up 87%
The Arena Group, publisher of Sports Illustrated, TheStreet, Parade and more, reported that Q2 gross profit, revenue and digital-ad revenue jumped.
Will JetBlue Take Away the One Thing People Like About Spirit?
The takeover of the budget airline raises a key question for consumers.
Micron and Nvidia: Buy or Sell After Bearish Updates?
Nvidia provided negative news on Monday and Micron followed up with more on Tuesday. Here's the trade.
Walmart Builds on Its Biggest Edge Over Amazon
Retailing giant Walmart wants to ensure its customers can get what they're looking for, however they want to buy it.